Delcath Systems, Inc. (NASDAQ:DCTH) Reports Results From Melphalan/HDS Application Accepted For Oral Presentation
Delcath Systems, Inc. (NASDAQ:DCTH) Reports Ongoing Patient Treatment In Intrahepatic Cholangiocarcinoma Trial Cohort
